Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )

Clinical trial NCT05221229 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05221229
Sponsor: University Hospital Birmingham
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Atrial Fibrillation Recurrence Overweight and Obesity Liraglutide

Start date: 2022-04-17
Primary completion: 2025-06-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.